Famotidine; Ibuprofen Patent Expiration

Famotidine; Ibuprofen is Used for relieving symptoms of rheumatoid arthritis and osteoarthritis while decreasing the risk of upper gastrointestinal ulcers in patients taking ibuprofen for these conditions. It was first introduced by Horizon Medicines Llc in its drug Duexis on Apr 23, 2011. 6 different companies have introduced drugs containing Famotidine; Ibuprofen.


Famotidine; Ibuprofen Patents

Given below is the list of patents protecting Famotidine; Ibuprofen, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Duexis US8067033 Stable compositions of famotidine and ibuprofen Jul 18, 2026 Horizon
Duexis US8067451 Methods and medicaments for administration of ibuprofen Jul 18, 2026 Horizon
Duexis US8309127 Stable compositions of famotidine and ibuprofen Jul 18, 2026 Horizon
Duexis US8318202 Stable compositions of famotidine and ibuprofen Jul 18, 2026 Horizon
Duexis US8449910 Stable compositions of famotidine and ibuprofen Jul 18, 2026 Horizon
Duexis US8501228 Stable compositions of famotidine and ibuprofen Jul 18, 2026 Horizon



Famotidine; Ibuprofen's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List



Famotidine; Ibuprofen Generics

Several generic applications have been filed for Famotidine; Ibuprofen. The first generic version for Famotidine; Ibuprofen was by Alkem Laboratories Ltd and was approved on Aug 3, 2021. And the latest generic version is by Endo Operations Ltd and was approved on Mar 22, 2024.

Given below is the list of companies who have filed for Famotidine; Ibuprofen generic.


1. ALKEM LABS LTD

Alkem Laboratories Ltd has filed for 1 generic for Famotidine; Ibuprofen. This 26.6mg;800mg version comes by the name IBUPROFEN AND FAMOTIDINE. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
26.6MG; 800MG

(reference standard)

tablet Prescription ORAL AB Aug 3, 2021


2. ASCENT PHARMS INC

Ascent Pharmaceuticals Inc has filed for 1 generic for Famotidine; Ibuprofen. This 26.6mg;800mg version comes by the name IBUPROFEN AND FAMOTIDINE. Given below are the details of the strengths of this generic introduced by Ascent Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
26.6MG; 800MG tablet Prescription ORAL AB Mar 15, 2023


3. ENDO OPERATIONS

Endo Operations Ltd has filed for 1 generic for Famotidine; Ibuprofen. Given below are the details of the strengths of this generic introduced by Endo Operations.

Strength Dosage Form Availability Application Pathway TE code Launch Date
26.6MG; 800MG tablet Prescription ORAL AB Mar 22, 2024


4. TEVA PHARMS USA

Teva Pharmaceuticals Usa has filed for 1 generic for Famotidine; Ibuprofen. This 26.6mg;800mg version comes by the name IBUPROFEN AND FAMOTIDINE. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
26.6MG; 800MG tablet Prescription ORAL AB Oct 29, 2021


5. TORRENT

Torrent Pharmaceuticals Ltd has filed for 1 generic for Famotidine; Ibuprofen. This 26.6mg;800mg version comes by the name FAMOTIDINE AND IBUPROFEN. Given below are the details of the strengths of this generic introduced by Torrent.

Strength Dosage Form Availability Application Pathway TE code Launch Date
26.6MG; 800MG tablet Discontinued ORAL N/A Mar 18, 2024